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Type 1 IFN Induction by Cytosolic Nucleic Acid Is Intact in
Neonatal Mononuclear Cells, Contrasting Starkly with
Neonatal Hyporesponsiveness to TLR Ligation Due to
Independence from Endosome-Mediated IRF3 Activation
Kiva Brennan,*,† Bobby D. O’Leary,‡ Danielle Mc Laughlin,x Eamon P. Breen,†
Emma Connolly,*,† Nusrat Ali,‡ David N. O’Driscoll,‡ Ema Ozaki,*,† Rebecca Mahony,*,†
Kelly Mulfaul,*,† Aoife M. Ryan,* Aine Ni Chianain,‡ Alison McHugh,‡ Eleanor J. Molloy,*,†,{
Andrew E. Hogan,*,‖ Sri Paran,x Fionnuala M. McAuliffe,‡,# and Sarah L. Doyle*,†
Twomillion infants die each year from infectious diseases before they reach 12mo; many of these diseases are vaccine preventable in
older populations. Pattern recognition receptors represent the critical front-line defense against pathogens. Evidence suggests that
the innate immune system does not fully develop until puberty, contributing to impaired response to infection and impaired vaccine
responses in neonates, infants, and children. The activity of the pattern recognition receptor family of cytosolic nucleic acid (CNA)
sensors in this pediatric population has not been reported. We show that in direct contrast to weak TLR-induced type I IFN in
human cord blood mononuclear cells, cord blood mononuclear cells are capable of initiating a potent response to CNA, inducing
both antiviral type I IFN and, unexpectedly, proinflammatory TNF-a. A deficiency in Rab11-GTPase endosome formation and
consequent lack of IRF3 activation in neonatal monocytes is at least in part responsible for the marked disparity in TLR-induced
IFN production between neonatal and adult monocytes. CNA receptors do not rely on endosome formation, and therefore, these
responses remain intact in neonates. Heightened neonatal responses to CNA challenge are maintained in children up to 2 y of age
and, in marked contrast to TLR4/9 agonists, result in IL-12p70 and IFN-g generation. CNA sensors induce robust antiviral and
proinflammatory pathways in neonates and children and possess great potential for use as immunostimulants or vaccine adjuvants
for targeted neonatal and pediatric populations to promote cell-mediated immunity against invasive infectious disease. The
Journal of Immunology, 2018, 201: 1131–1143.
N
eonates and infants are unduly susceptible to a wide
variety of infections. Although many viral infections
produce disease that is often severe in neonates com-
pared with children or adults, the incidence of admittance to in-
tensive care units (ICU) because of confirmed viral infection is
low and has been estimated at 1% of infants admitted to ICU in
one Dutch study (1). In contrast, bacterial infections account for
the majority of admissions to both neonatal and pediatric ICU
(2–4). The observation that viral infections, anecdotally, are less
life-threatening in neonates and infants than bacterial infections
was of particular interest to us. This implies that the pediatric
population may have intact functional responses to viral when
compared with bacterial infections, responses that could be har-
nessed pharmacologically to boost the immune system in neonates
and infants.
Differences in the immune responses of adults and neonates have
been a subject of interest in recent years (5), with gathering evi-
dence to suggest that TLR-mediated responses elicited by the
innate immune system of neonates, infants, and young children
are significantly different compared with those in adults (6). TLRs
are pattern recognition receptors (PRRs), a receptor family com-
prising the primary initiators of the immune response bridging
innate and adaptive systems to induce rapid and efficient host
defense mechanisms. PRRs comprise a number of subfamilies,
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including membrane-bound TLRs, and cytosolic Nod-like recep-
tors, RIG-I–like receptors (RLRs), and dsDNA sensors (7–10).
Early studies demonstrated impairment of neonatal TLR4-
induction of TNF-a (11), the mechanism of which was later at-
tributed to soluble plasma factors, such as adenosine, found in
cord blood plasma (12). TLRs activate a number of downstream
signaling pathways to orchestrate an immune response. In addition
to inducing TNF-a, a number of TLRs engage the IFN regulatory
factor (IRF) pathway to induce type I IFNs (9). Like TNF-a,
TLR4-induced IFN-b has also been shown to be impaired in cord
blood cells compared with adult cells (13). It is likely that these
differences contribute to the inability of infants to mount an ef-
fective immune response both to certain invasive pathogens and to
vaccine formulations.
Our understanding of how the innate immune system recognizes
viral nucleic acid in adults has grown exponentially over the past
decade (8). Cytosolic RLRs and dsDNA sensors have both been
reported to be essential for induction of innate immune responses
to viral infection (14, 15). However, to date, there have been no
investigations into the presence or activity of the cytosolic intra-
cellular nucleic acid–sensing PRRs and their downstream path-
ways in neonates and infants. In this study, we show that all
cytosolic nucleic acid (CNA) sensor agonists tested in cord blood
mononuclear cells (CBMCs) resulted in robust induction of IFN-a
production equivalent or greater than those elicited from PBMCs,
and unexpectedly, all CNA sensor agonists induced marked, en-
hanced production of proinflammatory TNF-a production from
neonates compared with adults. We show that deficiency in
Rab11a-positive endosome formation in neonatal monocytes is, at
least in part, responsible for the difference observed in type I IFN
production between neonates and adults in response to TLR4
ligand versus CNA. Finally, we show that the heightened neonatal
responses to CNA challenge are maintained in healthy children up
to 2 y of age and that CNA challenge alone induces IL-12p70 and
IFN-g in neonates, whereas TLR4 and TLR9 agonists did not. Our
data indicate that harnessing the proficiencies of CNA sensors
may have utility for stimulating the developing immune system in
the neonatal and pediatric populations.
Materials and Methods
Subjects
Umbilical cord blood samples were obtained from term births following
normal pregnancy, labor, and delivery at National Maternity Hospital
(NMH). All infants had an uncomplicated postnatal course and Apgar
scores of 9 at 5 min. Venous blood from infants, children, and adolescents of
various ages was collected during elective surgical procedures in which no
indication of infection was present (such as hydrocele repair, umbilical
hernia repair, onychocryptosis, or orchipexy repair) in Our Lady’s Child-
ren’s Hospital, Crumlin (OLCHC). In all cases, children had an extra
1–10 ml of blood drawn postanesthetic, thus avoiding extra venupuncture.
Volumes drawn were age and weight dependent according to standard,
approved guidelines. Ethics approval was obtained from the Ethics Com-
mittees of NMH and OLCHC, and informed consent was obtained from
each subject or their parent/guardian. Adult blood samples were from
healthy adults, supplied by the Irish Blood Transfusion Service.
Isolation of mononuclear cells and monocytes
Primary PBMCs or CBMCs were isolated from healthy human blood or
cord blood. Monocytes were isolated by negative selection using Monocyte
Isolation Kit II (Miltenyi Biotec). Monocyte purity was assessed using
CD14 staining and was routinely 85–95%. Cells were cultured at 37˚C, 5%
CO2, 95% air in RPMI 1640, with stable 2.5 mM L-glutamine and 0.5 mM
sodium pyruvate with 10% FBS (all from Sigma-Aldrich).
Stimulation of PBMCs and CBMCs
LPS (100 ng/ml) (Enzo Life Sciences), CL075 (5 mg/ml), and CpG oli-
gonucleotide (ODN) 2395 (1 mM) (both from InvivoGen) were used to
activate TLR4, 8, and 9, respectively. Polyinosinic–polycytidylic acid
[Poly(I:C)] (5 mg/ml) (InvivoGen), poly(deoxyadenylic-deoxythymidylic)
acid [Poly(dA:dT)] (5 mg/ml) (Sigma-Aldrich), 2939 cyclic guanosine
monophosphate–adenosine monophosphate (cGAMP) (10 mg/ml), 59 tri-
phosphate (ppp) dsRNA (2.5 mg/ml), and HSV60 (2 mg/ml) (all from
InvivoGen) were transfected into PBMCs or CBMCs using TransIT-X2
(Mirus Bio).
Measurement of cytokines
HEK-Blue TNF-a/IFN-a/b assays were performed as per manufacturer’s
instructions using QUANTI-Blue Detection Reagent. Secreted embryonic
alkaline phosphatase (SEAP) levels were determined using a spectropho-
tometer plate reader at 630 nm. IFN-a (3425-1H-6; Mabtech) and IP-10
(DY266; R&D Systems) were detected by sandwich ELISA. IFN-a ELISA
used pan-specific IFN-a Abs, which allows detection of IFN-a sub-
types 1/13, 2, 4, 5, 6, 7, 8, 10, 14, 16, and 17. BioLegend LEG-
ENDplex Human Inflammation Panel (13-plex) was carried out as per
manufacturer’s instructions to determine levels of IFN-g, IL-10, IL-
12p70, and IL-23. A BD LSRFortessa cell analyzer was used to
acquire samples, and BioLegend LEGENDplex software was used for
analysis.
IRF3/7 activation
Active Motif TransAM IRF3 and IRF7 assays were carried out on nuclear
extracts from PBMCs or CBMCs and harvested as per manufacturer’s
instructions to detect and quantify IRF3 or IRF7 activation.
Cell viability
A lactate dehydrogenase (LDH) cytotoxicity assay kit (Pierce) was used to
measure cell death in response to stimulation as per manufacturer’s instruc-
tions. The absorbance was read at 490 nm, and background (absorbance at
680 nm) was subtracted. A CellTiter 96 AQueous Non-Radioactive Cell Pro-
liferation Assay [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay] (Promega) was also used to
measure cell viability through assaying mitochondrial function, according to
manufacturer’s instructions. Absorbance was read at 490 nm on a 96-well
plate spectrophotometer.
Quantitative RT-PCR
Total RNA from PBMCs or CBMCs was extracted using TRIzol extraction
as previously described (16) and was reverse transcribed using M-MLV
Reverse Transcriptase (Promega) according to the manufacturer’s protocol.
This cDNA served as template for amplification of target genes, along with
the housekeeping gene bActin, by real-time PCR with SensiFAST SYBR
Green (Bioline) to determine the relative amounts of CXCL10, IFN-a, and
TNF-a mRNA. The ABI 7900HT system (Applied Biosystems) was used
for real-time PCR, and the cycling threshold method (22(DDCt)) was used
for relative quantification by comparative method after normalization to
bActin expression. The primers used were: CXCL10 forward 59-AGCA-
GAGGAACCTCCAGTCT-39, reverse 59-ATGCAGGTACAGCGTACA-
GT-39; IFN-a forward 59-TGAAGGACAGACATGACTTTGG-39, reverse
59-TCCTTTGTGCTGAAGAGATTGA-39; Rab5 forward 59-ACGGGCC-
AAATACGGGAAAT-39, reverse 59-AGAAAAGCAGCCCCAATGGT-39;
Rab7 forward 59-CAGACAAGTGGCCACAAAGC-39, reverse 59-AAGTG-
CATTCCGTGCAATCG-39 Rab10 forward 59-CCTCAGAAAGCCCGA-
GTGAG-39, reverse 59-GTCGTACGTCTTCTTCGCCA-39; Rab11 forward
59-CTTCGGCCCTAGACTCTACA-39, reverse 59-CACTGCACCTTTGGCTT-
GTT-39; TNF-a forward 59-CTGGGCAGGTCTACTTTGGG-39, reverse 59-
CTGGAGGCCCCAGTTTGAAT-39. IFN-a primers were designed to detect
IFN-a subtypes 2, 5, 6, 8, 14, 16, 17, and 21.
Flow cytometry
PBMCs or CBMCs were labeled for the investigation of dendritic cell (DC)
or monocyte subsets with the following fluorochrome-labeled Abs: CD45
(2D1), CD16 (3G8), CD14 (M5E2), CD66b (G10F5), CD11c (3.9), Lineage
(CD3, CD14, CD16, CD19, CD20, CD56), HLA-DR (L243), and CD123
(6H6) (All from BioLegend). Each staining well contained 4 3 105 cells;
cells were stained with LIVE/DEADAqua (Molecular Probes) followed by
staining for 20 m on ice, washed, and analyzed by flow cytometry im-
mediately. Gating during analysis was based on fluorescence minus one
controls. For transfection efficiency investigation, PBMCs or CBMCs were
transfected with Poly(I:C) fluorescein (5 mg/ml) (InvivoGen) for 24 h and
analyzed for percentage fluorescein expression as a measure of transfection
efficiency. Flow cytometry was carried out on a BD LSRFortessa cell
analyzer and analyzed using FlowJo software (Tree Star).
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CD14+ monocytes, negatively selected from PBMCs or CBMCs, were
seeded on Nunc Lab-Tek II Chamber Slide system. LPS was sonicated for
30 s and preincubated in serum-containing medium at 37˚C for 5 m before
being added to cells. Cells were stimulated with LPS (1 mg/ml) for 1 h.
Cells were fixed in 2% paraformaldehyde, permeabilized in 0.05% Triton
X-100, and stained with goat anti-human Rab11 (K-15) (Santa Cruz
Biotechnology) at 10 mg/ml and anti-goat Alexa Fluor 647 at 4 mg/ml or,
for costaining, rabbit anti-human Rab11 (ab3612) and mouse anti-human
TLR4 (ab22048), and anti-rabbit Alexa Fluor 488 and anti-mouse Alexa
Fluor 647. Cells were mounted using ProLong Gold Antifade Mountant
with DAPI. Images were captured using an Axio Observer Z1 inverted
microscope equipped with a Zeiss LSM 700 T-PMT scanning unit and a
403 plan apochromat objective. Image analysis was carried out using
LSM Image Browser.
Statistical analyses
Data were analyzed with GraphPad Prism software. Normality testing was
carried out using Shapiro–Wilk, Kolmogorov–Smirnov, and D’Agostino–
Pearson omnibus normality testing. When datasets were found to follow a
nonnormal distribution, a Kruskal–Wallis with Dunn multiple comparison
test or Mann–Whitney U test was carried out. Statistical analysis on nor-
mal datasets was performed with Student t test when two individual
experimental groups were analyzed. For multiple comparisons, ANOVA
was used with a Bonferroni posttest. Two-tailed tests were used through-
out, and the statistical approaches were all deemed to be valid for each
individual experiment.
Results
Previous studies have reported that LPS- and CpG-induced type I IFN
production is decreased in neonatal cells in comparisonwith adult cells
(13, 17). Using HEK-Blue–IFN-a/b reporter cells, we confirmed this
observation in PBMCs and CBMCs (n $ 30) (Fig. 1A, 1B). Data in
Fig. 1A–E are represented as both bar charts and dot plots. CL075, a
TLR7/8 agonist, also induced significantly lower levels of IFN-a/b
production from CBMCs compared with PBMCs (n = 35), albeit in a
less marked manner (Fig. 1C). In contrast, mimicking viral infection
through activation of cytosolic RLR/dsDNA sensors with transfected
Poly(I:C) and Poly(dA:dT) showed no inhibition of type I IFN pro-
duction in CBMCs when compared with PBMCs (n $ 39) (Fig. 1D,
1E). Transfection-only controls were also carried out (Supplemental
Fig. 1A). Untransfected Poly(I:C), as a TLR3 agonist, was also used
to stimulate PBMCs and CBMCs or isolated monocytes from adult
and cord blood, and, as expected from the literature (17), type I IFN
responses were decreased in neonatal cells (Supplemental Fig. 1B,
1C). MTS and LDH assays were performed on stimulated PBMCs
and CBMCs to assess whether cell death occurred in either cell type
in response to TLR, RLR, or dsDNA sensor ligation that might skew
the results; however, no differences were observed between cell types
(Fig. 1F, 1G). Dot plots for MTS and LDH assays are shown in
Supplemental Fig. 1D and 1E.
To ensure we were comparing like with like, we assessed the
subpopulations of mononuclear cells in our neonatal CBMC prep-
arations and our adult mononuclear cell preparations. Leukocyte
percentages in PBMCs and CBMCs were measured via flow
cytometry, and, based on CD45+ staining, no significant difference
in leukocyte percentage frequency was found between adult and
neonatal mononuclear cells (Fig. 2A). DC populations were also
measured, as plasmacytoid DCs (pDCs) are excellent producers of
Type I IFN (18). Lineage HLA-DR+ DC cells were analyzed for
expression of CD123 and CD11c, markers of pDCs and conven-
tional DCs (cDCs), respectively. No significant difference in the
populations of either pDCs or cDCs that might account for differ-
ences in cytokine production was observed when comparing adult
and neonatal cells (Fig. 2B). Potential differences in monocyte
populations between adult and cord blood were also investigated.
Total monocytes were characterized as CD66b2CD14+CD11c+ and,
based on their expression of CD16 and level of expression of CD14,
were further characterized as classical (CD14+CD162), patrolling
(CD14intermediateCD16+), or inflammatory (CD14+CD16+) mono-
cytes. No significant differences in any of these monocytes pop-
ulations were observed when comparing mononuclear cells isolated
from adult and cord blood (Fig. 2C). We next investigated whether
there was any differential transfection efficiency between neonatal
and adult mononuclear cells. Fluorescein-labeled Poly(I:C) was
transfected into cells, and fluorescein uptake was measured via flow
cytometry. No significant difference was noticed in transfection
efficiency of adult versus neonatal cells (Fig. 2D). Monocytes were
isolated through negative selection from PBMCs or CBMCS to a
purity of.85%. As observed in Fig. 2E, monocytes showed similar
trends of IFN production as those observed from total adult and
neonatal mixed mononuclear cell populations. Dot plots are shown
in Supplemental Fig. 2. We were unable to isolate sufficient num-
bers of pDCs from our preparations to check pDC responses by
ELISA, and flow cytometric analysis of type I IFN was unfeasible.
Our data indicated that differences observed between neonatal and
adult responses to ligands of TLRs and similarities observed be-
tween neonatal and adult responses to ligands of CNA sensors
were a result of differences in intracellular signaling pathways and
not due to alterations in cell population, viability, or transfection
efficiency.
Next, we performed IFN-a ELISAs on cells supernatants from
adult or neonatal mononuclear cells treated with LPS, CpG ODN,
transfected Poly(I:C), or transfected Poly(dA:dT) (n $ 23). Sim-
ilar trends and significant differences were seen for the IFN-a
ELISA as had been observed in the IFN-a/b SEAP assays, with
significantly decreased TLR4/9-induced IFN-a responses but
equivalent or enhanced CNA sensor responses in neonates com-
pared with adults (Fig. 3A–D). Alternative preparations of nucleic
acid (e.g., 59 ppp dsRNA and HSV60) are suggested to specifically
activate RIG-I and IFI16, respectively; similarly, 2939 cGAMP is
the direct ligand for STING (19–21). These agonists were tested
for their ability to induce IFN-a from adult and neonatal cells
(n $ 18). In all cases, the levels of IFN-a produced in response to
these ligands was lower than that in response to either Poly(I:C) or
Poly(dA:dT); nevertheless, CBMCs responded equally well or
with enhanced IFN-a production when compared with PBMCs
(Fig. 3E–G). To ensure that this increase in neonatal IFN-a pro-
duction was not linked to an increase in cell death, cell viability
was assayed via MTS assay in cells treated with CNA agonists
and compared with unstimulated controls. No difference in cell
viability was observed between PBMCs and CBMCs following
nucleic acid stimulation (Fig. 3H).
IFN-a is an antiviral cytokine particularly relevant for host
defense against intracellular pathogens as it promotes a Th1 type
immune response (22). TNF-a also promotes a Th1-type response.
TNF-a has previously been studied in the neonatal setting in re-
sponse to TLR agonists but not in response to CNA sensors.
Following our novel observation that CNA induced an increase in
production of IFN-a in neonatal compared with adult mononu-
clear cells, TNF-a production in response to CNA was investi-
gated in more detail. TNF-a was measured in supernatant of
PBMCs and CBMCs treated with Poly(I:C)-, Poly(dA:dT)-,
dsRNA-, cGAMP-, or HSV60-transfection or LPS, CL075, or
CPG ODN for 4, 8, or 24 h (n $ 29). Interestingly, all CNA tested
induced significantly more TNF-a production from neonatal cells
than from adult cells (Fig. 4A–E). In contrast, no significant dif-
ference in TNF-a production was observed from CBMCs and
PBMCs treated with TLR agonists LPS or CL075 (Fig. 4F, 4G).
CpG ODN did not induce any production of TNF-a from either
PBMCs or CBMCs (Fig. 4H).
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Thus far, we had observed differential regulation of IFN-a that
was broadly delineated between responses to cytosolic receptors
versus responses to membrane-bound receptors, with type I IFN
responses intact or enhanced in neonates in response to CNA but
attenuated in response to TLR4/7/8/9 activation. The ability of
neonatal cells to induce equal levels of TNF-a as adult PBMCs in
FIGURE 1. Differential regulation of neonatal IFN-a/b secretion between membrane-bound TLRs and CNA sensors. (A–G) Adult PBMCs or neonatal
CBMCs were stimulated with (A) LPS, (B) CpG ODN, (C) CL075, (D) Poly(I:C) transfection, or (E) Poly(dA:dT) transfection for 4, 8, or 24 h. Levels of
IFN-a/b were assayed via HEK-Blue IFN-a/b SEAP assay. Cell viability, following 24 h stimulation with ligands, was assayed using (F) MTS assay or (G)
LDH assay. Data in the upper panels of (A)–(E) are mean 6 SEM (n $ 30 donors in each group), with individual responses shown in lower panels. Data
in (F) and (G) are mean 6 SEM (n = 10 donors in each group). (A–E) Kruskal–Wallis nonparametric test with Dunn posttest was used to compare groups.
(F and G) The p value was determined by ANOVA and Bonferroni posttest. *p , 0.05, **p , 0.01.
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FIGURE 2. Frequencies of IFN-producing leukocyte subsets are similar in adult and cord blood. Adult PBMCs or neonatal CBMCs were isolated and
stained with Abs to distinguish between cell subsets. (A) Leukocytes were gated on based on expression of CD45, and percentage leukocyte population was
compared between PBMCs and CBMCs. (B) DCs were gated on as follows: CD45+Lin-HLA-DR+ and analyzed for percentage frequency of CD11c+
CD1232 (cDCs) or CD11c2CD123+ (pDCs). (C) Monocytes were gated on as follows: CD45+CD66b2CD11c+ and analyzed for percentage frequency of
CD14+CD162 (classical monocytes), CD14 intermediate CD16+ (patrolling monocytes), or CD14+CD16+ (inflammatory monocytes) (D) PBMCs or
CBMCs were transfected with Poly(I:C) fluorescein. Following 24 h incubation, the percentage of fluorescein+ cells was analyzed. (E) Monocytes, isolated
from adult or cord blood, were transfected with Poly(I:C) or Poly(dA:dT) or treated with LPS or CpG as indicated. Levels of (Figure legend continues)
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response to TLR activation (Fig. 4F, 4G) indicated that cell sig-
naling from these receptors to NF-kB is fully intact. Furthermore,
the ability of neonatal cells to secrete IFN-a in response to CNA
indicates that the process of type I IFN secretion is not affected.
The implication is that factors specific for the signaling pathway
to IFN-a/b induction downstream of TLRs (but not CNA sensors)
are inhibited in some manner. To verify this, real-time quantitative
PCR was used to measure levels of mRNA expression of TNF-a,
IFN-a, and CXCL10 in response to Poly(I:C), Poly(dA:dT), LPS,
or CpG ODN (n $ 4). There was no significant difference in
TNF-a levels in response to either CNA transfection or LPS
stimulation between PBMCs or CBMCs (Fig. 5A, dot plots shown
in Supplemental Fig. 3A). In contrast, gene expression levels of
IFN-a and CXCL10, an IFN–inducible gene, were inhibited in
CBMCs in response to CpG and LPS, respectively, when com-
pared with the PBMC response. In contrast, there was no inhibi-
tion of transcription of either IFN-a or CXCL10 in CBMCs in
response to CNA stimulation (Fig. 5B, 5C, Supplemental Fig. 3B,
3C). Together, these data indicate the TLR-induced signaling
pathway to IFN gene expression is inhibited in a manner that does
not affect the signal transduction pathway used by CNA sensors to
induce gene expression of IFN.
IRF3 and IRF7 are implicated as transcription factors activated
downstream of PRR ligation to induce type I IFN. IRF7, in par-
ticular, is thought to be important for the induction of IFN-a
(23, 24). We hypothesized that IRF7 activation would be enhanced
in CBMCs in response to Poly(I:C) transfection when compared
with IRF7 activated by TLR4 or TLR9 ligation. Intriguingly, we
found that IRF7 was not significantly activated by LPS, CpG, or
Poly(I:C) transfection in the CBMCs (n = 4); by striking contrast,
LPS, CpG, and Poly(I:C) all activated IRF7 in adult PBMCs (n = 5),
with percentage increases in activation over basal IRF7 between
150 and 250% (Fig. 5D, Supplemental Fig. 3D). Aksoy et al. (13)
have previously shown that impaired IRF3 DNA binding and CBP
interaction in neonatal DCs exposed to LPS are associated with
impaired expression of IFN-b and IFN-inducible genes. As men-
tioned, both IRF3 and IRF7 are implicated as transcription factors
for both IFN-a and IFN-b, so we next investigated whether, in
contrast to LPS-induced impaired IRF3 activation in neonates, Poly
(I:C) transfection might promote activation of IRF3 DNA binding.
We observed an ∼20% increase in IRF3 activation above basal
levels in response to either LPS or CpG stimulation in CBMCs,
indicating significant but low levels of IRF3 activation (n = 4). On
the other hand, Poly(I:C) transfection resulted in an ∼80% increase
in IRF3 activation above basal levels in CBMCs (n = 4) (Fig. 5E,
Supplemental Fig. 3E).
Together, these results indicate that IRF7, although expressed,
may not be activated in neonates and that the signaling pathway to
activate IRF3 to induce IFN-a transcription is muted in CBMCs in
response to LPS and CpG when compared with the efficient re-
sponse to CNA. In support of this observation, we assessed the
production of CXCL10 from PBMCs and CBMCs in response to
CNA transfection or LPS stimulation (n $ 29). There was no
significant difference in the CXCL10 response between PBMCs or
CBMCs to either Poly(I:C) or Poly(dA:dT) transfection (Fig. 5F,
5G, Supplemental Fig. 3F, 3G); however, LPS-induced CXCL10
secretion was significantly decreased in CBMCs compared
with PBMCs (Fig. 5H, Supplemental Fig. 3H). This observation
highlights that induction of IFN-a transcription and the subse-
quent IFN response appear fully functional downstream of CNA
transfection in CBMCs, in direct contrast to TLR stimulation of
CBMCs, in which transcription of IFN-a appears to be signifi-
cantly inhibited with consequent subduing of the IFN response.
A key difference between TLR induction of IFN-a/b and CNA
induction of IFN-a/b is TLR dependence on endosomal locali-
zation to engage with TRAF3 and the IRFs. Several Rab GTPases
have been reported to be involved in trafficking TLRs to endo-
somes (25). Of particular interest, in the absence of Rab11a,
IFN-a/b production in response to Escherichia coli is significantly
decreased, whereas TNF-a induction is unchanged (26). There-
fore, we investigated the expression and function of Rab11a in
PBMCs versus CBMCs. Real-time quantitative PCR was used to
investigate basal levels of Rab GTPase mRNA in PBMCs and
CBMCs. Rab11a levels were found to be significantly lower in
CBMCs compared with PBMCs (Fig. 6A) Strikingly, Rab11a
was the only Rab GTPase with an expression profile that was
significantly different between CBMCs and PBMCs, and Rab5,
Rab7, and Rab10 all showed comparable mRNA expression be-
tween CBMCs and PBMCs (n $ 9) (Fig. 6B–D, Supplemental
Fig. 4B–D). We next investigated if Rab11+ve endosome formation
was impaired in neonatal monocytes when compared with adult
monocytes. CD14+ve monocytes were isolated from CBMCs and
PBMCs (n = 3). Adult monocytes showed abundant accumulation
of Rab11+ve endosomes in response to LPS stimulation (Fig. 6E,
upper panels). Rab11+ve endosomes were not observed to the same
extent in neonatal monocytes in response to LPS (Fig. 6E, lower
panels). Fig. 6F (Supplemental Fig. 4E) depicts the significant
difference between the percentage of adult and neonatal cells with
detectable Rab11 following LPS treatment. There is a clear inhi-
bition of Rab11+ve endosome formation in neonatal monocytes in
response to LPS stimulation when compared with adult monocytes
(p = 0.00011). To further support our findings, we investigated
whether LPS-induced TLR4 colocalization with Rab11a would be
less evident in neonatal monocytes. Accumulation of Rab11+ve
endosomes in response to LPS stimulation was observed in adult
monocytes, with colocalization with TLR4 indicated by white
arrowheads (Fig. 6G, left-hand side panels). Again, Rab11+ve
endosomes were difficult to observe in neonatal monocytes in
response to LPS and are indicated by red arrow heads and did not
appear to colocalize with TLR4 (Fig. 6G, right hand side panels).
Given the literature on the reliance of LPS-induced type I IFN on
Rab11a, it seems likely that this is one mechanism by which
neonatal cells constrain the immune response to Gram-negative
bacteria.
To assess if CNA-induced IFN-a and TNF-awere a peculiarity
of neonatal cord blood or whether these responses were main-
tained into infancy and early childhood, blood samples from
healthy children in various age groups (4–24 mo; 2–5 y; 6–11 y)
undergoing elective surgery were collected and assayed for their
ability to produce both type I IFN (n $ 17) and TNF-a (n $ 16).
As can be seen in Fig. 7A and 7B, the production of type I IFN
in response to Poly(I:C) and Poly(dA:dT) was maintained
throughout childhood. This maintenance of cord blood respon-
siveness to CNA was also observed for both Poly(I:C)- and
Poly(dA:dT)-induced TNF-a production to the age of 24 mo
(Fig. 7C, 7D).
IFN-a/b were assayed via HEK-Blue IFN-a/b SEAP assay. Dot plots and histograms in (A)–(D) are representative of$5 individual donors. Graphs in (A)–(E) are
mean 6 SEM (n $ 5 donors in each group). (A–D) Student t test was used to test for significant difference between groups. (E)The p value was determined by
ANOVA and Bonferroni’s posttest. **p , 0.01.
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Given the potential of Poly(I:C) transfection to induce sub-
stantial IFN-a and TNF-a production in neonates and infants and
consequently give rise to a Th1-type immune response desirable in
vaccine-induced adaptive immunity, we sought to explore the
polarizing ability of Poly(I:C) transfection on IL-12p70, an im-
portant mediator of such responses (n = 21) (27–31). IL-12p70
levels were low, as expected in a mixed population of cells;
however, despite this, a similar significantly enhanced response to
Poly(I:C) transfection was found in CBMCs compared with
PBMCs (Fig. 8A). IL-12p70 was measured in a multiplex assay
which included the analyte IFN-g. IFN-g is the primary cytokine
that defines Th1 cells and is produced predominantly by CD4+
Th1 and CD8+ cytotoxic T cells, creating a positive feedback loop
causing naive CD4+ cells to differentiate into Th1 cells (32). To
our great surprise, Poly(I:C) transfection induced striking levels of
IFN-g, which was also significantly increased in CBMCs com-
pared with PBMCs (Fig. 8B), despite the lack of a T cell activator
(e.g., anti-CD3). IFN-g is secreted at low concentrations by
macrophages, NK cells, and NKT cells as part of the innate im-
mune response, is an important activator of both macrophages and
NK cells, and induces expression of MHC class I and II (33).
Levels of Th17-supporting cytokine IL-23 and anti-inflammatory
IL-10 production were low but detectable, with no significant
difference between adult and cord blood cells noted (Fig. 8C, 8D).
The source of the observed IFN-g secreted by CBMCs in response
to Poly(I:C) transfection remains to be identified in future
experiments; however, the high levels of IFN-g and enhanced
IL-12p70 secretion implies that the environment created through
activation of CNA sensors, in a mixed blood cell population,
would be tailored toward promoting a Th1-mediated cellular
FIGURE 3. Neonatal IFN-a secretion is attenuated in response to TLR ligation but enhanced in response to CNA. PBMCs or CBMCs were treated with
(A) LPS or (B) CpG ODN or transfected with (C) Poly(I:C), (D) Poly(dA:dT), (E) 59 ppp dsRNA, (F) 2939 cGAMP, or (G) HSV60 for 8 or 24 h, as indicated,
and IFN-a was measured by ELISA. (H) Cell viability following 24 h treatment was assayed using MTS assay. (A–G) Graphs show mean 6 SEM (n $ 18
donors in each group). (H) Graph compares mean 6 SEM of n = 10 donors in each group **p , 0.01, ***p , 0.005 as determined by ANOVA and
Bonferroni posttest.
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immune response. To determine whether Poly(I:C) transfection
might present a better adjuvant option for pediatric vaccine design
than LPS and CpG analogs currently in use or in development
(34–36), IL-12p70, IFN-g, IL-10, and IL-23 were also measured
in CBMCs in response to LPS (n = 20) or CpG (n $ 16). In direct
contrast to the cytokine profile observed in CBMCs transfected
with Poly(I:C), neither LPS nor CpG activation of PBMCs or
CBMCs resulted in detectable IL-12p70 (Fig. 8E, 8I) or secretion
of IFN-g (Fig. 8F, 8J). Again, IL-23 and IL-10 levels were low,
with no significant difference between adult and neonatal mono-
nuclear cells noted in response to LPS or CpG (Fig. 8G, 8K, 8L).
Dot plots are shown in Supplemental Fig. 4F–Q.
Discussion
Noting the potential disparity in neonatal and pediatric morbidity
between bacterial and viral infections in ICU admissions, we
speculated that infants were perhaps better equipped to fight viral
infection than bacterial infection. Viruses and bacteria are both
recognized by a variety of PRRs; however, as viruses produce
dsRNA in the cytosol to replicate, CNA sensors are highly adapted
to generate a robust antiviral response, including the induction of
type I IFNs and cellular immunity. We were interested in assessing
the ability of CNA to induce a type I IFN response in neonates and
children. In this article, we report for the first time, to our
knowledge, that stimulating CBMCs with a variety of dsRNA or
dsDNA mimics results in strong induction of type I IFN compa-
rable with responses in adults. A previous report by Renneson
et al. (37) showed that CMV-infected moDCs produce high levels
of IFN-a but lower levels of IL12 and IFN-b. Interestingly, we
found no evidence of IFN-b production in our system in re-
sponse to CNA activation (data not shown), and, similar to CMV
infection, the type I IFN produced in response to CNA activation
was predominantly IFN-a. We also confirm published reports that
neonatal TLR4 and TLR9 are less able to induce a proin-
flammatory response when compared with adult PBMCs (5, 11,
17, 38). It is important to note that the relative contributions of
TLRs and CNA sensors in the detection of many viruses are in-
completely understood.
Several studies have reported conflicting data on the subpopu-
lations of various cell types and total cell numbers in adult versus
cord blood (39–42). Of particular interest, Drohan et al. (40) have
reported increased frequency of pDCs in cord blood, although
several recent studies observed similar frequencies of pDCs be-
tween adult and cord blood (43, 44). Owing to the ability of pDCs
to produce high amounts of Type I IFN (18), it was important to
characterize the DC subsets in our cohort. Following isolation of
mononuclear cells, we found no differences in leukocyte per-
centages and no differences in DC subsets between adult and cord
blood. We also found that classical and inflammatory monocyte
subsets are the same between cord and adult mononuclear cells, an
observation previously reported in the literature (42, 45, 46) but in
conflict with another report that suggested that decreased pop-
ulations of monocytes could be responsible for observed hypo-
responsiveness to LPS seen in neonates (41). Importantly, within
our cohort, we found that monocytes isolated from either adult or
neonate stimulated with CNA or TLR ligands mirrored the IFN
response observed in the PBMC/CBMC system. Unfortunately,
technical limitations precluded the defining of the cell subsets
responsible for the production of intracellular Type I IFN, and we
were unable to isolate sufficient numbers of DCs from our
samples to check their responses by ELISA; therefore, at this
time, we cannot rule in or out the role of pDCs. Data from
FIGURE 4. TNF-a secretion from CBMCs is enhanced compared with adult PBMCs in response to a range of CNA receptor agonists. PBMCs or
CBMCs were transfected with (A) Poly(I:C), (B) Poly(dA:dT), (C) 59 ppp dsRNA, (D) 2939 cGAMP, or (E) HSV60 or treated with (F) LPS, (G) CL075, or
(H) CpG ODN for the indicated timepoints. Following stimulation, supernatant was harvested from the cells, and TNF-a was measured using HEK-Blue
TNF-a assay and made relative to 125 pg/ml TNF-a. Graphs show means 6 SEM (n $ 29 donors in each group). Kruskal–Wallis nonparametric test with
Dunn posttest was used to test for significant difference between groups. *p , 0.05, **p , 0.01, ***p , 0.005.
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Figs. 1 and 2E, however, demonstrate that monocytes are un-
questionably involved in the production of Type I IFN in our
experimental system.
It appears that in our system, altered cell subsets are unlikely to
play a role in the divergent regulation of IFN in response to CNA or
TLR ligands. In fact, our data demonstrating parity in cell signaling
downstream of TLR4/7/8/9 to TNF-a induction in both neonates
and adults highlighted the striking disparity in cell signaling to
IFN induction downstream of TLR4/7/8/9 and the CNA sensors.
The signaling pathways leading to the production of IFN-a are
largely shared between the various receptors beyond adaptor level.
A key difference between TLR-induced type I IFN and CNA in-
duction is TLR dependence on endosomal localization to engage
with TRAF3 and the IRFs. Several Rab GTPases have been
reported to be involved in trafficking TLRs (25). Of particular
interest, in response to LPS stimulation or E. coli infection, type I
IFN production relies on the regulation of TLR4 transport to
sorting phagosomes by Rab11a. In the absence of Rab11a, IFN
production is significantly attenuated, whereas TNF-a induction is
unchanged (26). Conversely, type I IFN responses downstream of
cytosolic receptors have no dependency on endosome formation
because of receptor location in the cytoplasm. We therefore in-
vestigated the expression and function of Rab11a in neonatal
CBMCs compared with adult PBMCs. Of four Rab GTPases
tested, basal expression of Rab11 was significantly lower in
CBMCs than in adult mononuclear cells. As mentioned previ-
ously, monocytes are unquestionably involved in Type I IFN
production in our system. This, along with previous reports on
the role of Rab11 in IFN production focusing on monocytes
and macrophages, led us to believe that monocytes were the
appropriate cell to investigate our hypothesis that Rab11 was re-
duced in cord blood cells.
FIGURE 5. Impaired TLR-induced IRF3 activation in CBMCs leads to attenuated IFN and ISG responses not observed in response to CNA. PBMCs or
CBMCs were transfected with Poly(I:C) or Poly(dA:dT) for 4 h (A and C) or 24 h (B), treated with LPS for 2 h (A) or 4 h (C), or treated with CpG ODN for
24 h (B), as indicated. Following stimulation, TRIzol extraction of RNAwas carried out, and induction of (A) TNF-a, (B) IFN-a, and (C) CXCL10 mRNA
expression was assayed by quantitative RT-PCR, normalized to b-actin, and presented relative to untreated, unstimulated adult PBMCs. (D and E) PBMCs
or CBMCs were treated with LPS for 15 min, CpG for 1 h, or transfected with Poly(I:C) for 1 h, and nuclear extracts were harvested and assayed for IRF7
or IRF3 activation via TransAM assays. (F–H) Cells were stimulated with Poly(I:C) or Poly(dA:dT) transfection or LPS as indicated, and protein levels of
CXCL10 were measured by ELISA. (A–E) Graphs show mean 6 SEM (n $ 4 donors in each group). (F–H) Graphs show mean 6 SEM (n $ 29 donors in
each group). *p , 0.05 as determined by Student t test or Kruskal–Wallis with Dunn posttest.
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FIGURE 6. Attenuation of Rab11-positive endosome formation in LPS-stimulated cord blood monocytes. (A–D) TRIzol extraction of RNA from PBMCs
or CBMCs was carried out, and expression of (A) Rab11, (B) Rab5, (C) Rab7, or (D) Rab10 mRNA was assayed by quantitative RT-PCR, normalized to
b-actin, and presented relative to adult PBMCs. (E and G) CD14-positive cells were isolated from adult PBMCs or neonatal CBMCs and left unstimulated
or treated with 1 mg/ml LPS for 1 h, as indicated. Cells were stained for Rab11 expression (red), DAPI (blue), or TLR4 (green) as indicated.
(F) Cells expressing detectable levels of Rab11 were counted and presented as a percentage of total cells (using .200 cells). (A–D) Graphs show mean 6
SEM (n $ 9 donors in each group). (E and G) Images are representative of three separate experiments; white arrows denote colocalization and red arrows
denote Rab11 alone. Scale bars, 10 mm (E) and 5 mm (G). (F) Graph shows mean percentage of cells expressing Rab11 of $200 cells from three individual
donors (6 SEM). *p , 0.05, ***p , 0.005 as determined by unpaired Student t test (A)–(D) or ANOVA and Bonferroni posttest (F).
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Upon LPS stimulation, the percentage of monocytes with de-
tectable Rab11+ endosomes was strikingly higher in adult mono-
cytes when compared with cord blood monocytes. Given our data
showing that the transcription of IFN-a was inhibited in CBMCs
in response to LPS, it seems plausible that a deficiency in Rab11-
positive endosome formation may account for the attenuated
IFN-a production in response to LPS in neonates. A requirement
for Rab11-positive endosome formation has not yet been attrib-
uted to TLR7/8/9, and as such, the mechanism underlying the
attenuation of IFN-a/b induction in response to CL075 or CpG in
neonates remains to be investigated.
Previously, Aksoy et al. (13) reported that LPS cannot induce
IFN-b in neonatal moDCs because of a lack of binding of IRF3
to CBP. Efficient interaction of IRF3 with its coactivator CBP
is essential for transcriptional activity of IFN genes. Our data
demonstrating that type 1 IFN induction is equivalent between
adult and neonatal mononuclear cells/monocytes downstream of
CNA stimulation would strongly imply that there is no integral or
inborn defect in the neonatal IRF3–CBP interaction in these cells
when compared with adults. This discrepancy could potentially be
due to cell type differences (i.e., moDCs versus monocytes) or it
could be that downstream of LPS, posttranslational modifications
of IRF3 required for CBP binding are defective in neonates be-
cause of the attenuation of the Rab11+ endosome trafficking of
IRF3; or it could be simply a limitation of the inherent variability
observed between cells isolated from human blood.
To assess whether the response to CNA observed in cord blood
was unique to cord blood or persisted through infancy and
childhood, we isolated PBMCs from children undergoing elective
surgery. The enhanced production of type I IFN in response to
cytosolic Poly(I:C) was maintained up to the age of two, at which
point it appears to level off to match adult levels. Poly(dA:dT)-
induced production of type I IFN was maintained across all age
groups. Interestingly, the induction of TNF-a in response to CNA
also remained steady up until the age of two, at which point it
drops to adult levels. Type I IFNs have critical roles in the in-
duction of adaptive immunity; they promote the generation of
cytotoxic T cell responses as well as a Th1-biased CD4+ T cell
phenotype (22). Type I IFNs drive cellular immunity by promoting
the activation and functional maturation of DCs, facilitating Ag
presentation to CD4+ T cells, cross-priming CD8+ T cells, and
inducing IFN-g and opsonizing Abs (22, 47). Initiating Th1
responses and cytotoxic T cells is vital in the fight against intra-
cellular pathogens, infections to which neonates are most sus-
ceptible, and are the holy grail for vaccine development (48).
Currently, a major obstacle for improving the impaired vaccine
responses observed in infants appears to be the lack of age-specific
adjuvants that can safely drive potent cellular immunity against
intracellular pathogens, resulting in the need for multiple booster
injections and in some cases delaying the administration of a
vaccine until a certain age has been reached. Aluminum salts
(alum) find wide clinical application as adjuvants and promote
FIGURE 7. CNA maintain strong type I IFN and TNF-a responses in healthy infants and children up to and beyond 24 mo. Mononuclear cells were
isolated from cord blood, adult blood, or from children’s blood collected from otherwise healthy children undergoing surgery for hydrocele repair, um-
bilical hernia repair, onychocryptosis, or orchipexy repair in OLCHC. Cells were transfected with Poly(I:C) or Poly(dA:dT) for 24 h. Following stimulation,
supernatant was harvested from the cells, and (A and B) IFN-a/b and (C and D) TNF-a were measured using HEK-Blue IFN-a/b or TNF-a assay and made
relative to 25 U/ml IFN-a or 500 pg/ml TNF-a, respectively. (A)–(D) show mean 6 SEM (cord, n $ 35; 4–24 mo, n = 22; 2–5 y, n $ 16; 6–11 y n $ 18;
adult, n $ 35). Stimulated populations were compared with stimulated cord mononuclear cells by Mann–Whitney U test. *p , 0.05, **p , 0.01.
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humoral immunity and Th2 cell responses. However, a major
disadvantage of alum is its limited ability to efficiently drive Th1
responses (49), motivating the search for targeted neonatal and
pediatric vaccine adjuvants, an unmet need recently highlighted in
a European Union–commissioned report on vaccines (50). We
tested the potential of cytosolic Poly(I:C) to promote a Th1 re-
sponse through measuring the production of Th1-polarizing
IL-12p70 and induction of IFN-g in adult and CBMCs. We
found that neonates produced significantly higher levels of both
IL-12p70 and IFN-g in response to CNA than adult PBMCs.
Conversely, there was no difference in levels of anti-inflammatory
IL-10 or Th17-polarizing IL-23 between neonates and adults ba-
sally or in response to cytosolic Poly(I:C). By comparison, neither
LPS nor CpG activation of CBMCs induced either IL-12p70 or
IFN-g. A recent study by Borriello et al. (51) has investigated the
adjuvancy potential of combining alum with activation of STING
in mice. This study, along with our work in human neonatal cells,
highlights the potential of these intracellular receptors in future vac-
cine development. From a physiological perspective, it is interesting
to speculate that infants have evolved constrained responses to bac-
terial infections to allow for appropriate commensal colonization of
the skin and gut without major inflammatory response, while at the
same time broadly conserving effective defense against inherent viral
pathogenicity by enabling CNA sensors to mount an efficient immune
response against invasive infection. Sharma et al. (52) have previ-
ously proposed a hierarchical maturation of innate immune defenses
in very preterm neonates, resulting in predominance of specific mi-
crobial infections in this age group. It is possible that a hierarchical
development of early cytosolic/endosomal PRR function, followed
later by extracellular/surface PRR function, may be essential to
balance the need to limit inflammatory signals to the adaptive im-
mune system during the critical period of the establishment of self-
tolerance in early life while preserving some responses to viruses.
Together, our data indicate that CNA and activators of CNA sensors
possess major potential to guide the neonatal immune response in the
direction of cell-mediated immunity and that this response is active
and robust in neonates and persists throughout childhood.
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